LOL.
I know exactly what it is, and I made it very clear what "I am talking about".
What it is most definitely NOT, is this:
"the fact that Cap raise requirements is 12 quarters away".
In NO way does it confirm as FACT that cap raise requirements are 12 quarters away. SIMPLE.
It is merely an over-simplistic estimation that is used to flag a potential for "running out of money", and hence it feeds into item 8.8, which essentially asks the company to explain how it can afford to fund the next 6 months IF they don't have enough funding to continue at the SAME level of operating cash flows for the next 2 qtrs.
The other poster absolutely misconstrued this item (8.7) and presented a claim of "fact" which is nonsense (which was my point, and you seem to agree btw), UNLESS the company continues at the SAME level of operating cash flows for the next 12 quarters, excluding debt etc.
Is that the plan?
Do you really think they can build a 50ktpa operation for under USD500M..?
Yeah, righto.
Good luck to anyone who believes that.
- Forums
- ASX - By Stock
- LKE
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-30
-
- There are more pages in this discussion • 202 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LKE (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.8¢ |
Change
-0.002(5.00%) |
Mkt cap ! $63.40M |
Open | High | Low | Value | Volume |
4.0¢ | 4.1¢ | 3.8¢ | $230.1K | 5.879M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
45 | 4289511 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.9¢ | 160348 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
44 | 4189511 | 0.038 |
29 | 2802808 | 0.037 |
25 | 1850530 | 0.036 |
30 | 3837186 | 0.035 |
6 | 643852 | 0.034 |
Price($) | Vol. | No. |
---|---|---|
0.039 | 160348 | 3 |
0.040 | 773696 | 12 |
0.041 | 662845 | 7 |
0.042 | 687425 | 8 |
0.043 | 478131 | 4 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
LKE (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online